The Baker Heart and Diabetes Institute is one of the few institutes in the world where the work of our staff spans from benchtop to bedside. The Institute has more than 300 scientists, scientific support staff, clinicians, health professionals and students who work across a range of laboratories undertaking research to tackle the deadly trio of diseases: cardiovascular disease, diabetes and obesity. This multi-faced approach ensures that the Institute brings everything to bear on these challenging health issues.
Atherothrombosis and Vascular Biology | Professor Karlheinz Peter
Biomarker Discovery | Associate Professor Bing Wang
Cardiac Cellular Systems | Dr Alex Pinto
Cardiac Hypertrophy | Professor Julie McMullen
Cardiovascular Endocrinology | Dr Morag Young
Cardiovascular Inflammation and Redox Biology | Professor Judy de Haan
Clinical Diabetes and Epidemiology | Professor Jonathan Shaw
Clinical Electrophysiology | Professor Peter Kistler
Computational Biology and Clinical Informatics | Associate Professor David Ascher
Diabetes Clinical Research | Associate Professor Neale Cohen
Diabetes and Population Health | Professor Dianna Magliano
Haematopoiesis and Leukocyte Biology | Professor Andrew Murphy
Heart Failure Research | Professor David Kaye
Human Autonomic Neurophysiology | Professor Vaughan Macefield
Human Integrative Physiology | Dr Erin Howden
Human Neurotransmitters | Professor Murray Esler
Imaging Research | Professor Tom Marwick
Inflammation and Cardiovascular Disease | Tin Soe Kyaw
Lipid Metabolism and Cardiometabolic Disease | Dr Anna Calkin
Lipoproteins and Atherosclerosis | Professor Dmitri Sviridov
Metabolomics | Professor Peter Meikle
Molecular Imaging and Theranostics | Associate Professor Xiaowei Wang
Molecular Metabolism and Ageing | Dr Brian Drew
Molecular Proteomics | Associate Professor David Greening
Neuropharmacology | Professor Geoff Head
Physical Activity | Professor David Dunstan
Preclinical Disease and Prevention | Associate Professor Melinda Carrington